Počet záznamů: 1
Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery
- 1.
SYSNO ASEP 0431499 Druh ASEP J - Článek v odborném periodiku Zařazení RIV J - Článek v odborném periodiku Poddruh J Článek ve WOS Název Rational design of urea-based glutamate carboxypeptidase II (GCPII) inhibitors as versatile tools for specific drug targeting and delivery Tvůrce(i) Tykvart, Jan (UOCHB-X) RID, ORCID
Schimer, Jiří (UOCHB-X) RID, ORCID
Bařinková, Jitka (UOCHB-X)
Pachl, Petr (UOCHB-X) RID, ORCID
Poštová Slavětínská, Lenka (UOCHB-X) RID
Majer, Pavel (UOCHB-X)
Konvalinka, Jan (UOCHB-X) RID, ORCID
Šácha, Pavel (UOCHB-X) RID, ORCIDCelkový počet autorů 8 Zdroj.dok. Bioorganic & Medicinal Chemistry. - : Elsevier - ISSN 0968-0896
Roč. 22, č. 15 (2014), s. 4099-4108Poč.str. 10 s. Jazyk dok. eng - angličtina Země vyd. GB - Velká Británie Klíč. slova GCPII ; PSMA ; structure-aided drug design ; specific drug targeting Vědní obor RIV CE - Biochemie CEP GBP208/12/G016 GA ČR - Grantová agentura ČR Institucionální podpora UOCHB-X - RVO:61388963 UT WOS 000339859700034 EID SCOPUS 84905081813 DOI 10.1016/j.bmc.2014.05.061 Anotace Glutamate carboxypeptidase II (GCPII), also known as prostate specific membrane antigen (PSMA), is an established prostate cancer marker and is considered a promising target for specific anticancer drug delivery. Low-molecular-weight inhibitors of GCPII are advantageous specific ligands for this purpose. However, they must be modified with a linker to enable connection of the ligand with an imaging molecule, anticancer drug, and/or nanocarrier. Here, we describe a structure-activity relationship (SAR) study of GCPII inhibitors with linkers suitable for imaging and drug delivery. Structure-assisted inhibitor design and targeting of a specific GCPII exosite resulted in a 7-fold improvement in K-i value compared to the parent structure. X-ray structural analysis of the inhibitor series led to the identification of several inhibitor binding modes. We also optimized the length of the inhibitor linker for effective attachment to a biotin-binding molecule and showed that the optimized inhibitor could be used to target nanoparticles to cells expressing GCPII. Pracoviště Ústav organické chemie a biochemie Kontakt asep@uochb.cas.cz ; Kateřina Šperková, Tel.: 232 002 584 ; Viktorie Chládková, Tel.: 232 002 434 Rok sběru 2015
Počet záznamů: 1